Literature DB >> 10675659

Analysis of the mRNA transcripts of the survival motor neuron (SMN) gene in the tissue of an SMA fetus and the peripheral blood mononuclear cells of normals, carriers and SMA patients.

Y J Jong1, J G Chang, S P Lin, T Y Yang, J C Wang, C P Chang, C C Lee, H Li, H M Hsieh-Li, C H Tsai.   

Abstract

Spinal muscular atrophy (SMA) is a disorder characterized by degeneration of the anterior horn cells of the spinal cord. The gene most highly associated with SMA is the survival motor neuron (SMN) gene. In this study, we present an analysis of messenger RNA (mRNA) expression of the SMN gene in peripheral blood mononuclear cells in normal subjects, SMA carriers and patients from 20 SMA families. We found at least 6-8 different transcripts of SMN gene formed by alternative splicing involving exons 3, 5 and 7. We compared transcripts from the different types of SMA and found no definite differences in transcript patterns and amounts. Normal subjects with the telomeric SMN (SMN(T)) gene only had variable splicing resulting in several transcripts, the most dominant being a transcript containing all coding regions. However, SMA patients with the centromeric SMN (SMN(C)) gene only had a higher degree of splice variation and tended to show little or no exon 7. These results demonstrate that SMN(T) and SMN(C) genes participate in alternative splicing phenomena. The different splicing patterns support the view that the SMN(T) gene is responsible for SMA disease. We also analyzed the transcripts from several tissues of an SMA fetus who had a homozygous SMN(T) gene deletion. Different splicing patterns were also found in these tissues, and were similar to the splicing pattern of leukocytes. We compared the major transcripts from exons 4 to 8 of both the SMN(T) and SMN(C) genes and found that the relative proportion varied among normal subjects, SMA carriers and patients. This approach could be used as a novel diagnostic method. We suggest that analyzing the mRNA expression of the SMN gene in peripheral blood mononuclear cells offers an apparently reliable technique for separating SMA patients, carriers, and normal individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675659     DOI: 10.1016/s0022-510x(99)00325-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  SMN dosage analysis and risk assessment for spinal muscular atrophy.

Authors:  Shuji Ogino; Robert B Wilson
Journal:  Am J Hum Genet       Date:  2002-06       Impact factor: 11.025

2.  Quantification of PCR bias caused by a single nucleotide polymorphism in SMN gene dosage analysis.

Authors:  Shuji Ogino; Robert B Wilson
Journal:  J Mol Diagn       Date:  2002-11       Impact factor: 5.568

3.  Spinal muscular atrophy genetic testing experience at an academic medical center.

Authors:  Shuji Ogino; Debra G B Leonard; Hanna Rennert; Robert B Wilson
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

4.  Heteroduplex formation in SMN gene dosage analysis.

Authors:  S Ogino; D G Leonard; H Rennert; S Gao; R B Wilson
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

5.  Predominant expression of exon 7 skipped SMN mRNAs in lung based on analysis of transcriptome sequencing datasets.

Authors:  Xiaoming Yang; Haihong Shen; Xue Gao; Xuexiu Zheng; Ryan Qin; Jianhua Zhou
Journal:  Neurol Sci       Date:  2013-08-18       Impact factor: 3.307

6.  Treatment of spinal muscular atrophy by sodium butyrate.

Authors:  J G Chang; H M Hsieh-Li; Y J Jong; N M Wang; C H Tsai; H Li
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  The RNA binding protein hnRNP Q modulates the utilization of exon 7 in the survival motor neuron 2 (SMN2) gene.

Authors:  Hung-Hsi Chen; Jan-Growth Chang; Ruei-Min Lu; Tsui-Yi Peng; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2008-09-15       Impact factor: 4.272

8.  Transcript, methylation and molecular docking analyses of the effects of HDAC inhibitors, SAHA and Dacinostat, on SMN2 expression in fibroblasts of SMA patients.

Authors:  Jafar Mohseni; Belal O Al-Najjar; Habibah A Wahab; Z A M H Zabidi-Hussin; Teguh Haryo Sasongko
Journal:  J Hum Genet       Date:  2016-06-02       Impact factor: 3.172

9.  Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.

Authors:  Claribel D Wee; Mallory A Havens; Francine M Jodelka; Michelle L Hastings
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

10.  A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls.

Authors:  Renske I Wadman; Marloes Stam; Marc D Jansen; Yana van der Weegen; Camiel A Wijngaarde; Oliver Harschnitz; Peter Sodaar; Kees P J Braun; Dennis Dooijes; Henny H Lemmink; Leonard H van den Berg; W Ludo van der Pol
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.